V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626382 | 330006577 | EXO | 0.95 | X292 | 1 | 2016-07-01 | NAB-PACLITAXEL | 330002686 | 330003330 | 330006578 |
| 16626383 | 330006577 | E1UZ0 | 2880 | X724 | 1 | 2016-07-01 | IFOSFAMIDE | 330002686 | 330003330 | 330006578 |
| 16626384 | 330006577 | EEI00 | 100 | X724 | 1 | 2016-07-01 | NOT CHEMO | 330002686 | 330003330 | 330006578 |
| 16626385 | 330006577 | EUZ | 2040 | X721 | 1 | 2016-07-09 | ETOPOSIDE | 330002686 | 330003330 | 330006578 |
| 16626386 | 330006577 | EEI00 | 0 | X721 | 1 | 2016-07-10 | VINCRISTINE | 330002686 | 330003330 | 330006578 |
| 16626387 | 330006577 | ELW | 139 | X724 | 1 | 2016-07-11 | CISPLATIN | 330002686 | 330003330 | 330006578 |
| 16626388 | 330006577 | EXO | 750 | null | 1 | 2016-07-11 | FLUOROURACIL | 330002686 | 330003330 | 330006578 |
| 16626389 | 330006577 | EN201 | 1500 | null | 1 | 2016-07-11 | FLUOROURACIL | 330002686 | 330003330 | 330006578 |
| 16626390 | 330006579 | ECL02 | 150 | null | 1 | 2016-01-16 | CETUXIMAB | 330002704 | 330003331 | 330006580 |
| 16626391 | 330006580 | EGU08 | 20 | null | 1 | 2014-07-08 | NOT CHEMO | 330002705 | 330010235 | 330006581 |
| 16626392 | 330006581 | EEI00 | 20 | null | 1 | 2015-03-16 | IFOSFAMIDE | 330002709 | 330007776 | 330006582 |
| 16626393 | 330006582 | EC4 | 885 | null | 1 | null | VINCRISTINE | 330002716 | 330003333 | 330006583 |
| 16626394 | 330006582 | EEI00 | 3840 | X722 | 1 | null | CYCLOPHOSPHAMIDE | 330002716 | 330003333 | 330006583 |
| 16626395 | 330006582 | ECL01 | 200 | X729 | 1 | null | ETOPOSIDE | 330002716 | 330003333 | 330006583 |
| 16626396 | 330006582 | EEI00 | 20 | X724 | null | null | NIVOLUMAB | 330002716 | 330003333 | 330006583 |
| 16626397 | 330006585 | ECL02 | 1800 | x724 | 1 | 2014-07-30 | MESNA | 330002732 | 330003334 | 330006586 |
| 16626398 | 330006585 | EXO | 3840 | X721 | 1 | 2014-07-31 | TOPOTECAN | 330002732 | 330003334 | 330006586 |
| 16626399 | 330006585 | EEI00 | 1 | X721 | 1 | 2014-07-31 | IFOSFAMIDE | 330002732 | 330003334 | 330006586 |
| 16626400 | 330006585 | EPH | 2950 | X724 | 1 | 2014-07-31 | NAB-PACLITAXEL | 330002732 | 330003334 | 330006586 |
| 16626401 | 330006585 | ECL02 | 2040 | X729 | 1 | 2014-07-31 | TRIAL | 330002732 | 330003334 | 330006586 |
| 16626402 | 330006586 | EGU08 | 0 | null | 1 | 2015-05-13 | CISPLATIN | 330002732 | 330003334 | 330006587 |
| 16626403 | 330006586 | EJR | 1.9 | X721 | 2 | 2015-05-20 | BUSULFAN | 330002732 | 330003334 | 330006587 |
| 16626404 | 330006586 | ECL02 | 68 | null | 1 | 2015-05-20 | CISPLATIN | 330002732 | 330003334 | 330006587 |
| 16626405 | 330006586 | EPH | 10 | X724 | 1 | 2015-05-21 | IFOSFAMIDE | 330002732 | 330003334 | 330006587 |
| 16626406 | 330006586 | ECL01 | 815 | X721 | 1 | 2015-05-21 | CYTARABINE | 330002732 | 330003334 | 330006587 |
| 16626407 | 330006586 | EEI00 | 2 | X721 | 1 | 2015-05-22 | IFOSFAMIDE | 330002732 | 330003334 | 330006587 |
| 16626408 | 330006586 | EJRNN | 1000 | null | 2 | 2015-05-22 | NOT CHEMO | 330002732 | 330003334 | 330006587 |
| 16626409 | 330006586 | EGQ01 | 1450 | X721 | 1 | 2015-05-22 | FLUOROURACIL | 330002732 | 330003334 | 330006587 |
| 16626410 | 330006586 | EN201 | 10 | X721 | 1 | 2015-05-22 | NOT CHEMO | 330002732 | 330003334 | 330006587 |
| 16626411 | 330006586 | EN4 | 7060 | X721 | 1 | 2015-05-22 | FLUOROURACIL | 330002732 | 330003334 | 330006587 |
| 16626412 | 330006587 | EGQ01 | 200 | null | 1 | 2017-09-25 | NIVOLUMAB | 330002736 | 330003336 | 330006588 |
| 16626413 | 330006587 | EEI00 | 20 | null | 2 | 2017-09-25 | FLUOROURACIL | 330002736 | 330003336 | 330006588 |
| 16626414 | 330006587 | ETG | 2880 | X721 | 1 | 2017-09-25 | ETOPOSIDE | 330002736 | 330003336 | 330006588 |
| 16626415 | 330006587 | EJRNN | 1748 | X724 | 1 | 2017-09-25 | TRIAL | 330002736 | 330003336 | 330006588 |
| 16626416 | 330006587 | ED301 | 814.5 | X292 | 1 | 2017-09-25 | NOT MATCHED | 330002736 | 330003336 | 330006588 |
| 16626417 | 330006589 | EGQ01 | 300 | X292 | 1 | 2015-05-27 | NOT CHEMO | 330002745 | 330003338 | 330006590 |
| 16626418 | 330006589 | EQM | 100 | X721 | 1 | 2015-05-27 | NOT CHEMO | 330002745 | 330003338 | 330006590 |
| 16626419 | 330006589 | ETG | 55 | X724 | null | 2015-06-17 | CYCLOPHOSPHAMIDE | 330002745 | 330003338 | 330006590 |
| 16626420 | 330006591 | EEI00 | 1 | X724 | 1 | 2017-07-16 | CYTARABINE | 330002747 | 330003340 | 330006592 |
| 16626421 | 330006592 | EEI00 | 0.75 | X731 | 1 | 2016-08-25 | CYTARABINE | 330002762 | 330003341 | 330006593 |
| 16626422 | 330006592 | EJRNN | 20 | X721 | 1 | 2016-08-25 | AZD9150 | 330002762 | 330003341 | 330006593 |
| 16626423 | 330006592 | EUZ | 1400 | X721 | 1 | 2016-09-01 | CYCLOPHOSPHAMIDE | 330002762 | 330003341 | 330006593 |
| 16626424 | 330006593 | ECL02 | 530 | null | 1 | null | AZACITIDINE | 330002765 | 330003342 | 330006594 |
| 16626425 | 330006593 | EC4 | 300 | null | 2 | null | NOT CHEMO | 330002765 | 330003342 | 330006594 |
| 16626426 | 330006593 | EGU08 | 2960 | null | 1 | null | CYCLOPHOSPHAMIDE | 330002765 | 330003342 | 330006594 |
| 16626427 | 330006593 | EEI00 | 640 | X721 | null | null | NOT CHEMO | 330002765 | 330003342 | 330006594 |
| 16626428 | 330006593 | EEI00 | 54 | null | 2 | null | NIVOLUMAB | 330002765 | 330003342 | 330006594 |
| 16626429 | 330006593 | EGQ01 | 0 | X724 | 1 | null | DACTINOMYCIN | 330002765 | 330003342 | 330006594 |
| 16626430 | 330006593 | ENW | 1300 | X721 | 1 | null | FLUOROURACIL | 330002765 | 330003342 | 330006594 |
| 16626431 | 330006593 | EE813 | 100 | null | 1 | null | CISPLATIN | 330002765 | 330003342 | 330006594 |